Schonfeld Strategic Advisors’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.99M | Buy |
218,500
+148,711
| +213% | +$2.04M | 0.02% | 708 |
|
|
2025
Q1 | $772K | Buy |
69,789
+1,689
| +2% | +$18.7K | ﹤0.01% | 1276 |
|
|
2024
Q4 | $725K | Sell |
68,100
-56,200
| -45% | -$599K | ﹤0.01% | 1198 |
|
|
2024
Q3 | $1.58M | Sell |
124,300
-124,099
| -50% | -$1.58M | 0.01% | 866 |
|
|
2024
Q2 | $4.17M | Buy |
248,399
+144,299
| +139% | +$2.42M | 0.03% | 528 |
|
|
2024
Q1 | $1.56M | Sell |
104,100
-27,800
| -21% | -$417K | 0.01% | 911 |
|
|
2023
Q4 | $1.98M | Buy |
131,900
+1,700
| +1% | +$25.5K | 0.01% | 741 |
|
|
2023
Q3 | $1.82M | Buy |
+130,200
| New | +$1.82M | 0.01% | 744 |
|